Anne‐Claire Mamez - Concepedia

Author

Anne‐Claire Mamez

University Hospital of Geneva ORCID

Also Known As

A C Mamez, A-C. Mamez, A. C. Mamez, Anne-Claire Mamez, Anne-claire Mamez, Anne‐Claire Mamez, Birgit Maier

Publications

695

Citations

H-Index

Concepts

All Affiliations

University Hospital of Geneva University of Geneva Inserm Université Paris Cité Assistance Publique – Hôpitaux de Paris

About

Anne‐Claire Mamez is an author at University Hospital of Geneva specializing in hematology, medicine, and transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	207
2	Blood Transplantation	5	5	130
3	Immunology	5	5	130
4	Cellular Therapies	2	2	51
5	Health Sciences	1	1	15

Anne‐Claire Mamez

Publications

388

Citations

H-Index

Page 1

	Year	Citations
Allogeneic stem cell transplantation for peripheral T cell lymphomas: a retrospective study in 285 patients from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC) Anne‐Claire Mamez, Axelle Dupont, Didier Blaise, Journal of Hematology & Oncology	2020	52
Precision and prognostic value of clone-specific minimal residual disease in acute myeloid leukemia Pierre Hirsch, Ruoping Tang, Nasséra Abermil, Haematologica	2017	46
Pre-treatment with oral hydroxyurea prior to intensive chemotherapy improves early survival of patients with high hyperleukocytosis in acute myeloid leukemia Anne‐Claire Mamez, Emmanuel Raffoux, Sylvie Chevret, Leukemia & lymphoma/Leukemia and lymphoma Hematological MalignancyMedian WbcMedicineAcute Myeloid LeukemiaMixed-phenotype Acute Leukemia	2016	45
Sustained HIV remission after allogeneic hematopoietic stem cell transplantation with wild-type CCR5 donor cells Asier Sáez‐Cirión, Anne‐Claire Mamez, Véronique Avettand-Fènoël, Nature Medicine TransplantationMarrow TransplantationHuman RetrovirusStem Cell TransplantationHematology	2024	42
Genetic T-cell receptor diversity at 1 year following allogeneic hematopoietic stem cell transplantation Stéphane Bühler, Florence Bettens, Carole Dantin, Leukemia Cell TherapyTransplantationMarrow TransplantationGeneticsT-regulatory Cell	2019	36
Invasive Mold Infections in Allogeneic Hematopoietic Cell Transplant Recipients in 2020: Have We Made Enough Progress? Romain Samuel Roth, Stavroula Masouridi‐Levrat, Yves Chalandon, Open Forum Infectious Diseases	2021	25
CMV Infection After Letermovir Primary Prophylaxis Discontinuation in Allogeneic Hematopoietic Cell Transplant Recipients Lara Chavaz, Léna Royston, Stavroula Masouridi‐Levrat, Open Forum Infectious Diseases	2023	21
Salvage Treatment of Refractory HSV Oral Lesions with Pritelivir in Allogeneic Hematopoietic Cell Transplant Recipients Davide Bosetti, Chiara Bernardi, M Maulini, Antimicrobial Agents and Chemotherapy Translational MedicineTransplantationSalvage TreatmentTransplantation MedicineHematology	2023	19
Fractionated gemtuzumab ozogamicin in association with high dose chemotherapy: a bridge to allogeneic stem cell transplantation in refractory and relapsed acute myeloid leukemia Pierre-Édouard Debureaux, Myriam Labopin, Anne‐Claire Mamez, Bone Marrow Transplantation Hematological MalignancyTransplantationOncologyGemtuzumab OzogamicinAcute Myeloid Leukemia	2019	17
Dynamics of virological and immunological markers of HIV persistence after allogeneic haematopoietic stem-cell transplantation in the IciStem cohort: a prospective observational cohort study María Salgado, Cristina Gálvez, Monique Nijhuis, The Lancet HIV Primary ImmunodeficiencyTransplantationMarrow TransplantationHuman RetrovirusStem Cell Transplantation	2024	17

Page 1